Skip to main content
Figure 1 | BMC Cardiovascular Disorders

Figure 1

From: Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort study

Figure 1

Kaplan-Meier survival curves for patients with dilated cardiomyopathy: the upper panel: patients with NT pro-BNP < 2247 pmol/L and NT pro-BNP > 2247 pmol/L with DCM (log-rank χ 2 = 35.588, P < 0.001). The middle panel: patients with hs-CRP < 3.90 mg/L and hs-CRP > 3.9 mg/L with DCM (log-rank χ 2 = 39.622, P < 0.001). The lower panel: patients with big-ET < 0.95 pmol/L and big-ET > 0.95 pmol/L (log-rank χ 2 = 17.890, P < 0.001).

Back to article page